Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 4.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,276 shares of the medical research company’s stock after buying an additional 105 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Agilent Technologies were worth $306,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its stake in shares of Agilent Technologies by 10.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,088,644 shares of the medical research company’s stock worth $141,131,000 after acquiring an additional 99,080 shares in the last quarter. Blair William & Co. IL boosted its position in shares of Agilent Technologies by 5.0% in the 2nd quarter. Blair William & Co. IL now owns 20,560 shares of the medical research company’s stock valued at $2,665,000 after purchasing an additional 985 shares during the period. Seven Eight Capital LP purchased a new position in Agilent Technologies in the 2nd quarter worth about $401,000. Brighton Jones LLC raised its holdings in Agilent Technologies by 3.8% during the 2nd quarter. Brighton Jones LLC now owns 4,468 shares of the medical research company’s stock worth $579,000 after buying an additional 163 shares during the period. Finally, Ieq Capital LLC lifted its stake in Agilent Technologies by 8.7% during the second quarter. Ieq Capital LLC now owns 16,224 shares of the medical research company’s stock valued at $2,103,000 after buying an additional 1,300 shares in the last quarter.

Agilent Technologies Trading Up 2.0 %

NYSE:A opened at $147.57 on Friday. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35. The firm has a market cap of $42.15 billion, a price-to-earnings ratio of 33.39, a P/E/G ratio of 3.71 and a beta of 1.06. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. The company’s 50 day moving average is $136.48 and its 200-day moving average is $137.19.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business’s revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.38 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a $0.248 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.67%. The ex-dividend date is Tuesday, December 31st. Agilent Technologies’s payout ratio is currently 22.40%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on A shares. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Barclays reduced their target price on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a report on Wednesday, November 27th. Bank of America lowered their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. JPMorgan Chase & Co. reduced their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Finally, StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $143.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.